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Case presentations
Patient 1. A 37-year-old man developed hypertension at age 18 when
he weighed 120.5 kg. He lost 50 pounds on a weight-reduction diet, and
his blood pressure fell to within normal range. At age 26, routine
physical examination disclosed a blood pressure of 140/100 mm Hg and
weight of 108.4 kg. Urinalysis was unrevealing; BUN was 18 mg/dl. An
intravenous pyelogram was reported to be normal. From age 26 to 32,
he was treated for hypertension with phenobarbital. At age 33, blood
pressure was noted to be 170/115 mm Hg. Administration of 50 mg of
hydrochlorothiazide daily and 10 mg of hydralazine three times daily
resulted in a fall in blood pressure to 120 to 130/88 to 90 mm 1-1g. At age
36, 4+ albuminuria was found for the first time; BUN was 26 mg/dl and
the serum creatinine was 1.7 mg/dl. Intravenous pyelography revealed
large kidneys with multiple bilateral cysts, and polycystic kidney
disease was diagnosed. This diagnosis was confirmed by ultrasound and
the patient was referred to New England Medical Center (NEMC) for
further evaluation. When first examined, he was asymptomatic. There
was no family history of polycystic kidney disease. He weighed 94 kg
and the blood pressure was 145/100 mm Hg (supine) and 130/I 10mm Hg
(standing). The rest of the physical examination was unremarkable.
The patient was encouraged to follow a weight-reduction diet, and his
dose of hydralazine was increased to 25 mg three times daily. Blood
pressure remained in the range of 130 to 140/100 to 105 mm Hg over the
next year, and the dose of hydralazine was increased to 50 mg three
times daily. When last examined at age 40, the patient's blood pressure
was 140/100 mm Hg and the serum creatinine was 1.8 mg/dl.
Patient 2. A 40-year-old woman, followed for many years at NEMC
for polycystic kidney disease, came from a family with a well-docu-
mented history of polycystic kidney disease. Her father and six of his
siblings had died of the disease between 30 and 36 years of age, and the
patient's older sister was known to have polycystic kidney disease.
When the patient was first evaluated at age 23, intravenous pyelography
revealed kidneys measuring 19 to 20 cm and containing multiple renal
cysts. Physical examination was normal except that palpation disclosed
bilaterally enlarged kidneys. Serum creatinine was 0.8 mg/dl. There was
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no history of hypertension, urinary tract infection, hematuria, or
abdominal pain.
Three years after the diagnosis was established, labile hypertension
was noted. Good blood pressure control was achieved with moderate
doses of various antihypertensive medications. The patient had no
evidence of urinary tract infection over this period save for a brief
episode, when she was 26 years old, of dysuria and pyuria with sterile
urine cultures. Serum creatinine remained in the 0.8 to 1.0 mg/dl range
until it rose to the 1.2 to 1.5 mg/dl range when the patient was 38 years
old.
At age 40 she developed progressive low back pain, lower abdominal
pain, fever to 103°F with shaking chills and diaphoresis, dysuria, and
increased urinary frequency. Physical examination was notable for a
blood pressure of 90/60mm Hg with orthostatic changes, a pulse of 88,
and a temperature of 37.9°C. The patient had warm skin with slightly
decreased turgor. The abdomen revealed bilaterally enlarged kidneys
that were minimally tender, and there was moderate bilateral costover-
tebral angle tenderness greater on the left than on the right. The
remainder of the physical examination was normal.
Laboratory data revealed normal electrolytes, a BUN of 19 mg/dl, a
serum creatinine of 1.3 mg/dl, a white blood cell count of 23,200 mm3
with a shift to the left, and a hematocrit of 37%. Results of urinalysis
revealed a specific gravity of 1.012; pH, 6; and a trace of protein.
Examination of the sediment revealed sheets of white blood cells, 5 to
10 red blood cells per high-power field, and 2+ bacteria on an unspun
specimen.
The patient was admitted to NEMC with a diagnosis of acute
pyelonephritis. She was given intravenous ampicillin and tobramycin,
and was rehydrated. Urine culture subsequently grew 50,000 to 100,000
colonies of E. co/i sensitive to ampicillin, and tobramycin administra-
tion was discontinued on the second hospital day. She remained febrile
to 39°C and had continued tenderness of the left kidney. A CT scan of
both kidneys on hospital day 6 showed an area of possible abscess
formation in the lower pole of the left kidney; the area was aspirated but
was culture negative. The fluid was turbid. The patient did not become
afebrile until day 8. She received a total of 2 weeks of intravenous
ampicillin therapy (8 g/day) followed by an additional week of oral
ampicillin. Urine culture was sterile at the time of discharge. When
examined 6 weeks after discharge, she had no urinary tract symptoms
and she had stable renal function and sterile urine.
Patient 3. A 48-year-old man had been in good health until age 31
years, when routine physical examination disclosed his blood pressure
to be 170/120 mm Hg. Physical examination also was remarkable for
palpable kidneys bilaterally and a ventral hernia. Intravenous pyelogra-
phy revealed polycystic kidney disease; renal size was described as
"three times normal." The family history was unremarkable for poly-
cystic kidney disease or other renal diseases.
Over the next 14 years, the patient did well save for one brief episode
of total, gross, painless hematuria. During this interval, the serum
creatinine rose to 5.4 mg/dl. Renal function continued to deteriorate and
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when at age 40 the serum creatinine was 9.3 mg/dl, hemodialysis was
instituted. At this time the patient's kidneys could be palpated easily
and they extended to the iliac crests. He remained well on dialysis
except for an exacerbation of preexisting asthma and a brief episode of
abdominal pain thought to be due to a ruptured hepatic or renal cyst.
Soon after dialysis was begun, the patient was evaluated for renal
transplantation. Because of the enormous size of the kidneys, bilateral
nephrectomy was performed to provide space for the grafted kidney.
The right kidney measured 32.0 cm in length, 20 cm at greatest width,
and it weighed 3550 grams. The left kidney measured 30.5 cm in length,
15 cm at maximum width, and it weighed 3030 grams. lntraoperative
examination of the liver revealed multiple large cysts measuring be-
tween 0.5 cm and 6 cm. The patient was discharged on the 10th
postoperative day. His postoperative course had been complicated only
by transient hypotension 3 days postoperatively that responded to
intravenous fluid administration. Ascites and pedal edema were noted 4
weeks postoperatively, but these resolved with aggressive dialysis.
Cadaveric renal transplantation was performed after one year of
hemodialysis.
Discussion
DR. WADI N. SuKI (Professor of Medicine and Chief Renal
Section, The Methodist Hospital, Baylor College of Medicine,
Texas Medical Center, Houston, Texas): The three patients
summarized here illustrate some interesting features of polycys-
tic kidney disease. The first and the third patients presented
with hypertension, not the most common mode of presentation
in this disorder. In the first patient, hypertension was recog-
nized at age 26; 10 years passed before polycystic kidney
disease was first diagnosed. In many instances, the diagnosis is
only made postmortem, although the patient may have suffered
from any one of the consequences of the disease. The second
patient, a woman with a strong family history of polycystic
kidney disease, was diagnosed at age 23. It was not until 3 years
later that she became hypertensive, and 12 years later her
serum creatinine predictably was elevated. Two years subse-
quent to that she developed an abscess, which responded only
after about 3 weeks of treatment; I will comment on this feature
subsequently. Polycystic kidney disease was diagnosed in the
third patient during an evaluation for hypertension when his
kidneys were found to be palpable. Nine years later dialysis was
begun because the patient was in renal failure, and nephrecto-
my was performed. The need and indications for nephrectomy,
particularly in preparation for transplantation, will be addressed
later in the discussion. Other interesting features of these 3
patients include the normal IVP in the first and the fact that 2 of
the 3 had negative family histories. This may seem unusual for
an autosomal dominant inherited disease, but a negative family
history is frequent in this disorder.
Incidence qf polycystic kidney disease. Adult polycystic
kidney disease is a fairly common disorder. It accounts for
approximately I in 3000 hospital admissions and has been
described in 1 in 200 to I in 1000 autopsies, with an average of I
in 500 [1]. The disease is clinically recognized much less
frequently, however. In fact, only a small proportion of patients
are diagnosed during life. Clear-cut adult polycystic kidney
disease was diagnosed premortem in only 25% of patients
shown to have the disease postmortem [21. Of the other 75%, at
least one-third had a clinical manifestation, such as hyperten-
sion or renal insufficiency, that should have led to recognition
of the disease. Dalgaard, in a study of Scandinavian patients,
estimated that by age 80 years, everyone who has inherited the
gene for polycystic kidney disease will have some manifestation
of the disease [31. But a patient could die at age 80 of unrelated
causes never having had overt clinical evidence of the disease
and yet cysts could be found at autopsy.
Dalgaard found the pattern of expression to be fairly uniform
in a particular family; in other words, the age at which clinical
expressions of the disease become manifest and the severity of
these expressions are fairly uniform among family members
who inherit the gene [31. We have encountered several excep-
tions to this assertion, however.
The disease, usually recognized in the third and fourth
decades of life, has been described in patients of all ages, from
neonates to the elderly. Involvement by cysts is usually diffuse
and bilateral, although occasional cases of unilateral disease [4]
and of highly localized disease [5] also have been described.
Clinical features of polycystic kidney disease. I shall restrict
my remarks about the clinical features to adult polycystic
kidney disease (Table I). I should point out immediately that
the term adult polycystic kidney disease is a misnomer; we
know now that "adult" polycystic kidney disease can occur at
any time from birth [6] to old age. For this reason, the term
autosomal dominant polycystic kidney disease has been pro-
posed to distinguish it from the autosomal recessive, or so-
called infantile type, which also occurs in adults [7].
In the study by RaIl and Odell, the most common presenting
complaint was heaviness and pain in the flank and abdomen [81.
The pain, often a pulling or tugging discomfort, usually is
moderate in severity but can be severe when associated with
bleeding, infection, or malignancy. The presence of pain seems
to correlate with the weight of the kidneys and the size of the
cysts. In one study, 50% of patients with pain had at least one
cyst measuring 3 cm or more in diameter; cysts of this size were
found in only 20% of asymptomatic patients [2]. Funck-Bren-
tano, Vantelon, and Lopez-Alvarez have reported, however,
that frequency and nocturia were the most common initial
complaints in their experience [9]. This observation is interest-
ing, especially because impaired concentrating ability is one of
the functional hallmarks of this disorder [101. Hematuria is the
second most common presenting complaint in this disease [3].
Gross hematuria frequently continues to punctuate the course
of patients with polycystic kidney disease. The bleeding can
lead to clot formation, obstruction, and renal colic-type pain.
Finally, hypertension occurs in approximately 70% of patients
who manifest the disease [31; another common clinical manifes-
tation is palpable kidneys [3].
Proteinuria is the most common laboratory finding [3, 81, but
it is rarely substantial and even more rarely in the nephrotic
range. Ackerman described 2 polycystic patients with advanced
renal failure, massive proteinuria, and hypoalbuminemia [1!].
Whether the proteinuria in these patients was solely the conse-
quence of polycystic kidney disease or whether it was due to
some superimposed process was not studied. Indeed, glomeru-
lonephritis superimposed on polycystic kidney disease has been
reported [121.
Stone disease occurs with some frequency in patients with
polycystic kidneys. The incidence in various series ranges from
5% to 15%, with an average of 10% [3, 13]. In my experience
and in that of several others, the stones usually contain calcium.
Hamburger and coworkers, however, report that the stones
may be composed mostly of urate [141. The composition of
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Table 1. Manifestations of adult polycystic kidney disease
Pain (most common complaint)
Urinary frequency
Palpable kidneys
Hematuria
Proteinuria (most common laboratory finding)
Stones
Malignancy (unilateral or bilateral)
Infection (sometimes abscess)
Hypertension
renal calculi in polycystic kidney disease and their pathogenesis
deserve more thorough investigation.
Renal cell carcinoma is bilateral in 20% of patients with
polycystic kidneys, whereas it is bilateral in only about 5% of
patients without polycystic kidney disease [15]. Therefore, if
one encounters a tumor in one kidney of a patient with
polycystic kidney disease, one should look carefully for a tumor
in the other kidney. Even if none is found, one should follow the
patient carefully.
Infection occurs frequently in polycystic kidney disease,
especially in women; 50% to 75% of patients have infection
sometime in the course of the disease [3, 81. The high infection
rate is only partly related to the increased frequency with which
patients with polycystic kidney disease have instrumentation of
the urinary tract. The polycystic kidney also is more susceptible
to infection than is the normal kidney. Kime Ct al rendered the
kidneys of experimental animals polycystic by chemical means,
and when these animals were injected with microorganisms, the
frequency of renal infection increased [16].
When hypertension complicates polycystic kidney disease, it
can occur quite early in the course of the disorder, frequently at
the time of diagnosis or soon thereafter. The onset of hyperten-
sion clearly antedates the onset of progressive renal functional
insufficiency. Renin and angiotensin do not seem to play a role
in the pathogenesis of the hypertension [17, 181; indeed, the
administration of the angiotensin II antagonist saralasin to these
patients usually does not lower blood pressure. This finding
supports the view that the hypertension in polycystic disease is
not renin dependent [191.
Polycystic disease often involves organs other than the
kidney. Extrarenal cysts most commonly occur in the liver,
where they usually are inconsequential. The benignity of liver
cysts in adult polycystic disease stands in sharp contrast to the
course of liver involvement by cysts in infantile polycystic
kidney disease. This latter disorder is often accompanied by
hepatic fibrosis, cirrhosis, hepatic failure, and portal hyperten-
sion. I should point out, however, that an occasional patient
with adult polycystic kidney disease has been described with
portal hypertension and esophageal varices [201 or jaundice
[211. Pancreatic cysts and an array of cysts in other organs also
occur.
Cerebral artery aneurysms occur in 5% to 16% of patients.
When the aneurysm is greater than one centimeter in diameter,
it generally is symptomatic and can rupture [221. Two papers
have reported abdominal aortic aneurysm in association with
polycystic kidney disease [23, 24]. However, this finding may
be merely an incidental occurrence in an adult disease associat-
ed with hypertension.
Of course, the most serious consequence of polycystic kid-
ney disease is progressive renal failure. In transplantation
registries, 5% to 8% of patients with end-stage renal disease
who undergo renal transplantation have polycystic kidney
disease [25, 26].
Functional aspects of polycystic kidney disease. Medical
students and house officers are often taught that patients with
polycystic kidney disease tend to be salt wasters. We have been
unable to confirm this assertion [27]. We studied one group of
patients with fairly well preserved renal function (7 patients
with a mean creatinine clearance of 58 mI/mm) and another
group with severely impaired renal function (6 patients with a
mean creatinine clearance of 10 mI/mm). Patients in both groups
were first given a diet containing 100 mEq of sodium and then a
diet containing 10 mEq of sodium. The patients with well-
preserved renal function conserved sodium appropriately on
the low-sodium diet. The patients with advanced renal insuffi-
ciency could not reduce urine sodium concentration to the same
level as did patients in the first group; also, they were in
negative sodium balance. This response, however, does not
differ in patients with the same degree of renal insufficiency
from other causes [28]. Urine sodium concentration does not
decrease abruptly to very low values in patients with advanced
or end-stage renal disease. Whether the increased urinary
sodium level is due to osmotic diuresis or to a natriuretic factor
is a subject for a separate discussion [29, 301.
Because hyperkalemia has been observed in some patients
with polycystic kidney disease and advanced renal failure, the
possibility exists that these patients might not be able to handle
potassium very well. In our studies, patients with severe renal
impairment did not excrete as much potassium as did the
patients with mild impairment [27]. If one calculates potassium
excretion as a percentage of the filtered potassium load, howev-
er, the patients with severe impairment excrete a high percent-
age of the filtered potassium load.
Hypercalciuria was not a feature, but we have not studied
patients with relatively well-preserved renal function who have
calcium-containing kidney stones. The explanation for stone
formation in these patients remains to be determined. Whether
the stones are due to local factors, loss of an inhibitor, or
excretion of a factor that promotes crystallization is not known.
The cysts in this disorder are functional and are also in a state
of dynamic equilibrium [3 1—34]. The careful studies of Lambert
[31] and other workers [32—34] suggest that the cysts can arise
from any segment of the nephron, and that they have the
characteristics of the particular nephron segment from which
they are derived. Proximal cysts, for example, have inulin,
creatinine, and electrolyte concentrations similar to those of
blood. Distal cysts have a sodium concentration three- to four-
tenths that in blood, whereas the concentration of inulin or
creatinine in the cyst is several fold that in blood. Perhaps the
only exceptions are glomerular cysts, which are "blind" and
nonfunctional [311. Both inulin and PAH appear in the cysts
after intravenous administration; thus some communication
with glomerular filtrate probably exists and the cells of the cyst
lining likely are functional [31, 32].
Hyperchloremic acidosis occurs in patients with polycystic
kidney disease, and Preuss et al reported that 2 of 4 patients
could not acidify the urine maximally [351. In this respect, these
patients do not seem to differ from patients with other forms of
renal disease. Salt-restricted patients with renal parenchymal
disease can acidify the urine when given sodium sulfate and
mineralocorticoids. But because Preuss et al did not use this
experimental protocol, it is not clear whether their patients with
polycystic kidney disease had a defect different from that
encountered in other patients with moderate to severe renal
disease. In Preuss' study, ammonium excretion was decreased
in 4 of 7 patients even when corrected for GFR; this finding
suggests that a tubular defect does exist [35].
Several years ago we reported that with few exceptions
patients with polycystic kidney disease tend to have an im-
paired ability to concentrate the urine, even when renal func-
tion is relatively well preserved [10]. The GFR in these patients
ranged between 60 and 165 mI/mm. Only 2 of 13 patients were
able to concentrate the urine greater than 900 mOsm/kg; the
other 11 had an impairment in the ability to concentrate the
urine maximally. We investigated this observation further to
determine whether concentrating ability becomes more im-
paired with advancing renal insufficiency. We found that the 8
patients with the most markedly depressed renal function also
had the most severely impaired tJfllax. Only one patient, howev-
er, had what one might label as hyposthenuria or nephrogenic
diabetes insipidus.
We studied the patients with an impaired Umax but well-
preserved GFR by giving them hypertonic saline, thus raising
their osmotic clearance. We then examined their capacity to
reabsorb solute-free water (T70). We observed four patterns.
In 2 patients, T,0 was at the top of the normal range. These 2
patients had the best-preserved GFRs (143 and 165 mI/mm). In 3
additional patients, T,0 was at the bottom of the normal range.
The GFR in these patients was 90, 102, and 117 mI/mm. In one
patient, Tko initially was at the bottom of the normal range,
but at a very high osmotic clearance it began to decrease (GFR,
109 mI/mm). In 2 others, T,0 was lower than normal through-
out the range of osmolar clearance (GFR, 60 and 97 mi/mm).
Although most of the patients with well-preserved GFRs had an
impaired ability to maximally concentrate the urine, their ability
to absorb solute-free water in the collecting tubule largely was
well preserved until renal functional impairment became
severe.
When the rate of flow in the distal nephron was increased by
hypertonic saline infusion in the patients with severe renal
dysfunction, osmotic equilibrium between tubular lumen and
the peritubular environment did not occur, and hypotonic urine
was produced; that is, free-water absorption became negative.
Free-water clearance measured during water diuresis was
normal in both groups; the thick ascending limb and distal
convoluted tubule, which are the major sites of dilution, appar-
ently were functioning normally. The impairment in concentrat-
ing capacity therefore must have been the consequence of
disordered function of the collecting tubules or of the medullary
countercurrent multiplication system.
We investigated urinary concentrating ability in rats with
experimentally induced polycystic kidney disease. Two chemi-
cals are known to induce polycystic changes in the kidneys of
experimental animals. One is diphenylamine and the other is 2-
amino, 4,5-diphenyl thiazole HCI. Vernier and his group report-
ed that rats treated with diphenylamine exhibited an impaired
ability to concentrate urine even before cystic changes ap-
peared in the nephron [361, and we confirmed that finding [371.
As in humans, however, the rat's ability to absorb solute-free
water in the collecting tubule was intact. Also as in humans,
their ability to dilute the urine and form solute-free water was
normal. Other studies in these rats revealed that glucose,
bicarbonate, chloride, and proximal tubular water absorption
(the latter measured by micropuncture as TF/P inulin) were
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Fig. 1. Intravenous pyelogram demonstrating
enlargement of the renal contour, stretching
of the infundibulae, and arched impressions
on the infundibulae and calyces caused by the
renal cysts.
Fig. 2. Nephroromogram showing areas of
diminished nephrogram density and distortion
of the collecting system caused by the renal
cysts.
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comparable to those in the normal rat; these findings suggested
that the tubular defect was in the more distal segments of the
nephron.
Diagnosis of polycystic kidney disease. Until recently, the
diagnosis of polycystic kidney disease depended on intravenous
pyelography and renal arteriography. Intravenous pyelography
usually reveals enlarged kidneys with an irregular contour,
stretching of the infundibulae of the calyces, and circular or
arched impressions on the calyces causing flattening and distor-
tion (Fig. 1). When the changes on standard intravenous
pyelography are not diagnostic, one can complement the study
with nephrotomography (Fig. 2). Arteriography has been used
in establishing the diagnosis (Fig. 3) and is currently one of the
mainstays in diagnosing some of the complications of polycystic
kidney disease, particularly malignancy. In my view it remains
the major method for detecting renal malignancy.
Ultrasonography [381 and computerized tomography [39] are
new and important diagnostic tools. Ultrasonography, a nonin-
vasive technique, has proved useful for screening patients'
families (Fig. 4), and it sometimes can be of value when one
suspects a solid tumor in the kidney. Computerized tomography
can demonstrate the configuration of both the kidneys and liver
(Fig. 5A, SB), determine whether obstruction is present, assess
whether there is a solid mass in the kidney, and evaluate
whether an abscess is present, merely from the difference in the
density of the fluid in a particular cyst.
Management of polycystic kidney disease. Because no one
has been able to document salt-wasting in these patients, one
need not urge the patient to ingest a high salt intake as one
would in a patient with medullary cystic disease. When the
patient is hypertensive, sodium intake should be reduced to 70
to 80 mEq/day. Patients with polycystic kidney disease have a
high incidence of hiatal hernia; therefore one should recom-
mend that the patient have small meals and not recline soon
after eating. The patient should avoid contact sports, rough
rides, seat belts, and tight belts around the abdomen. Whelton
reported ruptured cysts and hematuria as a consequence of
patients wearing automobile or airplane seat belts [401. When
hematuria occurs, bed rest alone is the best treatment. Occa-
sionally the hematuria can be severe enough to cause obstruc-
tion of a kidney. This presents a problem, because introduction
of a ureteral catheter to bypass the obstruction can lead to
infection. One also could use fibrinolytic preparations in an
attempt to lyse the clots and speed up their evacuation.
As I mentioned earlier, one of the presenting manifestations
of adult polycystic kidney disease is pain. When the pain is
severe and protracted, one should consider the possibility of a
renal stone, infection, or tumor. It is difficult to diagnose a renal
tumor in a patient with polycystic kidney disease because the
manifestations of tumor—pain, hematuria, fever, and calcifica-
tion—are features of polycystic kidney disease itself, especially
when complicated by infection. When the index of suspicion is
high, renal arteriography may be required if noninvasive tests
fail to exclude a tumor.
At one time, the Rovsing procedure was performed on large
cysts suspected of causing pain or when kidney size was very
large. In 1957, Bricker and Patton studied renal function before
and after this operation in patients with polycystic kidney
disease [411. Their comparison of operated patients with those
who did not undergo operation disclosed a 20% loss of renal
function in the operated group. Since then, this procedure has
been discarded.
Infection deserves special comment, because clinicians agree
neither on the method nor on the duration of treatment for this
complication. Certain lessons can be learned from studies of
cyst fluid obtained at the time of surgery. The cyst concentra-
tions of antibiotics administered in standard doses prior to the
procedure were not optimal, reaching only 10% to 25% of the
concentrations in blood [42]. The concentrations of the antibiot-
ics in the distal tubular cysts were even lower than those in
proximal cysts. These observations provide a rationale for
treating patients with infected cysts with high doses of antibiot-
ics for protracted periods.
Cerebral aneurysms generally do not lead to any harmful
effects unless they are 1 cm in diameter or larger. Stones and
hernias present other important challenges in management.
The management of renal failure is conservative until the
patient requires renal replacement therapy. At that point,
hemodialysis is an acceptable form of treatment and has been
widely used [43]. Peritoneal dialysis also can be employed in
these patients; unless the kidneys are huge—and the kidneys
often do shrink as the patients go into renal failure or are
dialysed [44]—I believe there is no contraindication to this form
of dialysis [451.
Transplantation is another feasible therapy for these patients
[431. The patient's diseased kidneys should be removed not
only when hypertension cannot be controlled by dialysis, but
also for other major complications of the disease, including: (1)
infection; (2) tumor; (3) severe, gross hematuria; (4) very large
kidneys, with or without ascites; and (5) nephrolithiasis, be-
cause stones predispose to infection. I believe that every
patient with polycystic kidneys should undergo arteriography
prior to renal transplantation. If a potential transplant recipient
is found to have neoplasia in one or both kidneys, bilateral
nephrectomy should be performed. If after I to 3 years such a
patient is free of tumor, renal transplantation can be reconsid-
ered. Of 11 patients who had malignancy (several with hyper-
nephroma) and who received renal transplants at least one year
after tumor resection, tumor recurred in only one patient after
transplantation [461.
In summary, polycystic kidney disease is a common cause of
end-stage renal disease. Major advances in our understanding
576 Nephrology Forum
Fig. 3. Selective renal arteriogram showing
distortion of the intrarenal vasculature and
the 'Swiss cheese" pattern caused by the
renal cysts.
Fig. 4. Ultrasonogram demonstrating
enlargement qf the kidney and the areas of
sonolucency caused by the renal cysts.
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of the pathophysiology and pathogenesis of this disease have
been made in the last 25 years. Unfortunately, we are not yet
able to halt the progressive decline in renal function, but current
methods of renal replacement therapy are as applicable in
patients with this disorder as they are in patients with other
types of renal disease.
Questions and answers
DR. JORDAN J. COHEN: You noted that an experimental
model of polycystic disease can be produced by administering
certain chemicals to an animal. This, of course, raises an
obvious question: Does this disease in humans stem from the
inheritance of a structural defect in the nephron that eventually
results in cyst formation, or does it result from the inheritance
of a metabolic defect that causes production of an injurious
circulating substance? The latter possibility might more easily
account for the variable age of onset of the disease and the
variable distribution of cysts in other organs. Are there any data
in humans that bear on this point, or are we left only with
speculation?
DR. SuKI: It is really all speculation. It fascinated us that one
of the earliest manifestations of this disease in humans is
impaired renal concentrating capacity. Similarly, there is im-
paired concentrating capacity in the experimental model before
there is any apparent structural change even by electron
microscopy. Perhaps what we inherit is not a structural defect
in the basement membrane of the nephron, but rather an
abnormal chemical which, upon prolonged exposure to the
basement membrane, dissolves it. I should add that one can
perfuse an isolated tubule in vitro under standard pressure, and
add collagenase to the medium, and the perfused tubule seg-
ment will balloon out.
Cuppage et al [341 and others have shown by electron
microscopy that the basement membrane in these cysts is
actually thickened and extensively laminated. The lingering
question is whether a basement membrane abnormality result-
ing in excessive compliance is the primary reason for the
development of the cyst, or whether cysts develop because of
tubular obstruction.
DR. COHEN: Do these chemicals produce cysts only in young
animals, or are adult animals affected as well?
DR. SuKI: The model can be produced most predictably when
the chemical is administered to young rats, but adult rats also
develop cysts.
DR. COHEN: It will be interesting, of course, to see whether
patients with polycystic kidney disease who receive renal
transplants develop recurrent cystic disease. Such an occur-
rence would provide strong evidence that a circulating factor is
responsible.
DR. SuKI: To date I know of no evidence of recurrence of
polycystic disease in transplanted kidneys.
DR. WARREN GooRNo (Nephrolo gist, Emerson Hospital,
Concord, Mass.): Dr. Suki, given the high incidence of malig-
nancy in patients with polycystic kidney disease, are there any
data on the incidence of malignancy after transplantation in
such patients? One would suspect that it might be even higher.
DR. SuKI: Tumors appear with some frequency in polycystic
kidney disease, but the true incidence is not known. Only about
50 cases of malignancy have been reported in polycystic kidney
disease. Whether the incidence of malignancy is exaggerated
further by immunosuppression, I do not know. There are no
good data regarding this point.
DR. JOHN T. HARRINGTON: I have another question on
malignancy. You stated that you perform bilateral arteriograms
before transplantation on all patients with polycystic kidney
disease. If you find a malignancy on one side, do you recom-
mend bilateral nephrectomy?
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DR. SuKI: Yes, for the following reasons. First, the chances
are high that the patient has or will develop a tumor on the
contralateral side. Second, this procedure avoids the need to
undertake major surgery after transplantation. In my experi-
ence, the postoperative management of patients with polycystic
kidney disease is difficult. They often develop ileus, ascites,
and infections. It is difficult surgery. I therefore suggest
nephrectomy and a waiting period of 1 to 2 months prior to
transplantation.
DR. HARRINGTON: Let me turn to a different issue. Polycystic
kidney disease always has fascinated me because it is one of the
few renal diseases in which high blood pressure frequently
develops in the absence of volume overload or a high renin-
angiotensin state. Is there any new information on the patho-
genesis of the hypertension in these patients?
DR. SUKI: None that I know of. As I indicated, the latest data
with saralasin show no response to the drug [191. The studies of
Nash [18] and others [17] of the renin-angiotensin system also
yielded negative results. One presumption is that the high blood
pressure is related to subtle volume expansion; the blood
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Fig. 5. (Upper) CT scan demonstrating a
massively cystic liver and cysts in the upper
pole of the left kidney. (Lower) Lower level qf
the same CT scan demonstrating cysts in both
markedly enlarged kidneys and a few cysts in
the liver.
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pressure does respond very well to diuretic administration.
DR. ANDREW LEVEY (Renal Service, NEMC): What do you
do for patients with massive bleeding into the urine?
DR. SUKI: This may be an indication for interventional
radiography. Embolization using autologous clot, balloons, or
small coils has been used to control massive uncontrollable
bleeding. I find the embolization technique an attractive possi-
bility in some of these patients with huge kidneys. One should
keep in mind, however, that pain may be a prominent complaint
for a day or so after this procedure.
DR. COHEN: Dr. Suki, you mentioned that occasionally you
find nephrotic-range proteinuria in patients with polycystic
kidney disease. That brings to mind the recent suggestion that
any form of chronic renal insufficiency can lead to secondary
glomerular injury in the remaining nephrons because of hemo-
dynamic alterations [47]. Is there any evidence of focal sclerosis
or other primary glomerular abnormalities in patients with
polycystic kidney disease?
DR. Sun: None that I know of. As I said, there is one report
of glomerulonephritis superimposed on polycystic kidney dis-
ease [12]. Also, Ackerman reported polycystic patients with the
nephrotic syndrome in whom no histologic diagnosis was made
[11]. It remains to be proven whether hyperfiltration really
produces focal sclerosis. Hyperfiltration does cause focal scle-
rosis in the renal infarction model, as shown by Morrison and
Hostetter [47—49]. In contrast, one does not see focal sclerosis
in another model of hyperfiltration, diabetes.
DR. BARRY STRAUBE (Renal Fellow, NEMC): Patients with
renal cysts generally have high red blood cell counts, and
patients with polycystic kidney disease seem to have higher
hematocrits for their degree of renal failure. Could you com-
ment on this finding?
DR. Sun: Relative erythrocythemia seems to be a feature of
polycystic kidney disease [50]. Erythropoietic material has
been found in the fluid contents of these cysts [51, 521. The
presumption is that these cysts produce the erythropoietic
factor, which in turn enters the blood and stimulates erythropoi-
esis.
DR. JAMES STROM (Chief Renal Division, St. Elizabeth's
Hospital, Boston): Has the occurrence of unilateral polycystic
kidney disease been well documented?
DR. SUn: Yes, there are occasional reports of unilateral
disease [4].
DR. LEVEY: How early in life can pathologic examination
establish the diagnosis of the adult form of polycystic kidney
disease?
DR. Sun: It is difficult to know because there are no
systematic studies. Some asymptomatic infants from families
with known polycystic kidney disease have been screened by
ultrasonography, and cysts have been found. We used tomogra-
phy to evaluate 10- and 12-year-old children of patients with
polycystic kidney disease and found cysts in many of these
children.
DR. NICOLAOS MADIAS (Chief, Renal Service, NEMC): How
about genetic counseling in this hereditary disorder?
DR. Sun: This is very important to patients with polycystic
kidney disease. What does one advise a couple about having
children if one of them has polycystic kidney disease? If the
disease could be detected in utero, one could theoretically offer
the option of abortion in those instances. But at present there is
no test to detect the disease in utero. Even if such a test were
available, however, the course of the disease is so highly
variable that the child might never have clinical disease. I
explain the facts about inheritance of the disease and the
consequences of having the disease and let the prospective
parents make the decision.
DR. STRAUBE: Do you screen family members?
DR. SUn: Screening is a debatable issue. One of the ques-
tions raised is, what is the purpose of learning that you
have polycystic kidney disease if you are asymptomatic? The
knowledge may evoke anxiety, decrease job opportunities, and
diminish insurability. I therefore do not recommend routine
screening of asymptomatic family members of patients with
polycystic kidney disease. If an individual develops hyperten-
sion, hematuria or proteinuria, of course, studies should be
carried out.
Reprint requests to Dr. W. Suki, Renal Section, Department of
Medicine, Baylor College of Medicine; The Methodist Hospital; Hous-
ton, Texas 77030, USA
References
I. DANOVITCH GM: Clinical features and pathophysiology of polycys-
tic kidney disease in man, in Cystic Diseases of the Kidney, edited
by GARDNER KD JR, New York, John Wiley and Sons, 1976, p. 125
2. HATFIELD PM, PFISTER RC: Adult polycystic disease of the
kidneys (Potter type III). JAMA 222:1527, 1972
3. DALGAARD OZ: Bilateral polycystic disease of the kidneys. A
follow-up of 284 patients and their families. Acta Med Scand
(suppl) 328:1, 1957
4. SELLERS AL, WINFIELD AA, ROSEN V: Unilateral polycystic
kidney disease. J Urol 107:527, 1972
5. HUTCHINS KR, MUI-IOLLAND SG, EnsoN M: Segmental polycystic
disease. NY State J Med 72:1850, 1972
6. KAY C, LEWY PR: Congenital appearance of adult type (autosomal
dominant) polycystic disease. J Pediatr 85:807, 1974
7. DUPOND J-L, MIGUET J-P, CARBILLET J-P, SAINT-HILLER Y,
PEROL C, LECONTE R: Kidney polycystic disease in adult congeni-
tal hepatic fibrosis. Ann Intern Med 88:5 14, 1978
8. RALL JE, ODELL HM: Congenital polycystic disease of the kidney:
Review of the literature and data on 207 cases. Am J Med Sci
218:399, 1949
9. FUNCK-BRENTANO JL, VANTELON J, LOPEZ-ALVAREZ R: Les
accidents evolitifs de Ia maladie polykystique des reins: 154 obser-
vations personelles. Presse Med 72:1583, 1964
10. MARTINEZ-MALDONADO M, YLUM JJ, EKNOYAN G, SUKI WN:
Adult polycystic kidney disease: Studies of the defect in urine
concentration. Kidney tnt 2:107, 1972
11. ACKERMAN GL: Nephrotic syndrome in polycystic renal disease. J
Urol 105:7, 1971
12. LICINA MG, ADLER 5, BRUNS FJ: Acute renal failure in a patient
with polycystic kidney disease. JAMA 245:1664, 1981
13. AMAR AD, DAS S, EGAN RM: Management of urinary calculous
disease in patients with renal cysts: Review of 12 years of experi-
ence in 18 patients. J Urol 125:153, 1981
14. HAMBURGER J, RICHET G, CR05NIER J, FUNCK-BRENTANO JL,
ANTOINE B, DUCROT H, MERY J-P, DEMONTERA H: Nephrology,
Philadelphia, WB Saunders, 1968, vol. II, p. 1070
15. No RCK, SUKI WN: Renal cell carcinoma occurring in a polycystic
kidney of a transplant recipient. J Urol 124:710, 1980
16. KIME SW JR, MCNAMARA ii, Lush 5, FARMER 5, 511 BERT C,
BRICKER NS: Experimental polycystic renal disease in rats: Elec-
tron microscopy, function, and susceptibility to pyelonephritis. J
Lab Clin Med 60:64, 1962
17. LEENEN FH, GALLA SJ, REDMOND DP, VAGNUCCI AH, MCDON-
ALD RH JR, SHAPIRO AP: Relationship of the renin-angiotensin-
aldosterone system and sodium balance to blood pressure regula-
tion in chronic renal failure of polycystic kidney disease. Metabo-
lism 24:589, 1975
580 Nephrology Forum
18. NASH DA JR: Hypertension in polycystic kidney disease without
renal failure. Arch Intern Med 137:1571, 1977
19. ANDERSON RJ, MILLER PD, LINAS SL: Role of the renin-angioten-
sin system in hypertension of polycystic kidney disease. Miner
Electrolyte Metab 2:137, 1979
20. DELGUERCIO E, GRECO J, KIM KE, CHINTZ J, SWARZ MD:
Esophageal varices in adult patients with polycystic kidney and
liver disease. N EngI J Med 289:678, 1973
21. ERGUN H, WOLF BH, HIssoNG SL: Obstructive jaundice caused
by polycystic liver disease. Radiology 136:435. 1980
22. WIEBERS DO, WHISNANT JP, O'FALLON WM: The natural history
of unruptured intracranial aneurysms. N Engl J Med 304:696, 1981
23. CHAPMAN JR, HILSON AJW: Polycystic kidneys and abdominal
aortic aneurysms. Lance! 1:646, 1980
24. MONTULIU J, TORRAS A, REVERT L: Polycystic kidneys and
abdominal aortic aneurysms. Lancet 1:1133, 1980
25. ADVISORY COMMITTEE TO THE RENAL TRANSPLANT REGISTRY.
Eleventh report of the human renal transplant registry. JAMA
226:1197, 1973
26. PARSONS FM, BRUNNER FP, BURCK HC, GRA5ER W, GURLAND
Hi, HARLEN H, SCHARER K, SPIES GW: Statistical report, in Proc
Eur Dial Transplant Assoc, edited by MOOREHEAD JF, BAILLOD
RA, MI0N C, London, Pitman, 1975, vol. Il, p.3
27. MARTINEZ-MALDONADO M, YIUM JJ, SUKI WN, EKNOYAN G:
Electrolyte excretion in polycystic kidney disease: Interrelation-
ship between sodium, calcium, magnesium, and phosphate. J Lab
Clin Med 90:1066, 1977
28. COLEMAN Ai, ARIAS M, CARTER NW, RECTOR FC JR: The
mechanism of salt wastage in chronic renal disease. J Clin Invest
45:1116, 1966
29. DANOVITCH GM, BOURGOIGNIE J, BRICKER NS: Reversibility of
the "salt-losing" tendency of chronic renal failure. N Engl J Med
296:14, 1977
30. BRICKER NS: Nephrology Forum: Sodium homeostasis in chronic
renal disease. Kid,Iey Jut 2 1:886—897, 1982
31. LAMBERT PP: Polycystic disease of the kidneys: A review. Arch
Pathol 44:34, 1947
32. BRICKER NS, PATTON iF: Cystic disease of the kidneys: A study of
dynamics and chemical composition of cyst fluid. Am J Med
18:207, 1955
33. GARDNER KD JR: Composition of fluid in twelve cysts of a
polycystic kidney. N EngI J Med 281:985, 1969
34. CUPPAGE FE, HUSEMAN RA, CHAPMAN A, GRANTHAM JJ: Ultra-
structure and function of cysts from human adult polycystic kid-
neys. Kidney mt 17:372, 1980
35. PREuss H, GEOBY K, JOHNSON M, CHESTER A, KLIGER A,
SCHREINER GE: Tubular function in adult polycystic kidney dis-
ease. Nephron 24: 198, 1979
36. SAFOUH M, CROCKER JFS, VERNIER RL: Experimental cystic
disease of the kidney. Sequential, functional, and morphologic
studies. Lab Invest 23:392, 1970
37. EKNOYAN G, WEINMAN EJ, TSAPARAS A, TISHER CC, YARGER
WE, SuKI WN, MARTINEZ-MALDONADO M: Renal function in
experimental cystic disease of the rat. fLab din Med 88:402, 1976
38. LUFKIN EG, ALFREY AC, TRUCK5ESS ME, HOLMES JH: Polycystic
kidney disease: Earlier diagnosis using ultrasound. Urology 4:5,
1974
39. SAGEL SS, STANLEY RJ, LEVITT RG, GEISSE G: Computed tomog-
raphy of the kidney. Radiology 124:359, 1977
40. WHELTON A: Seat belts and polycystic kidneys. Lancet 2:273, 1978
41. BRICKER NS, PATTON iF: Renal function studies in polycystic
disease of the kidneys—with observations on the effects of surgical
decompression. N EngI J Med 256:212, 1957
42. MUTHER RS, BENNET WM: Cyst fluid antibiotic concentrations in
polycystic kidney disease: Differences between proximal and distal
cysts. Kidney Jut 20:5 19, 1981
43. DEBONO DP, EVANS DB: The management of polycystic kidney
disease with special reference to dialysis and transplantation. Q J
Med 46:353, 1977
44. THAYSEN JH, CHRISTENSEN E, ALARCON-ZURITA A, MOVILD B:
Involution of polycystic kidneys during active treatment of terminal
uremia. Acta Med Scand 197:257, 1975
45. NAKOMOTO S, KOIFF Wi: Chronic uremia due to polycystic renal
disease treated with artificial kidney. Arch Intern Med 101:921,
1958
46. MATAS AJ, SIMMONS RL, BUSELMEIER Ti, KJELLSTRAND CM,
NAJARIAN iS: Successful renal transplantation in patients with
prior history of malignancy. Am J Med 59:791, 1975
47. HOSTETTER TH, OLSON JL, RENNEE HG, VENKATACHALAM MA,
BRENNER BM: Hyperfiltration in remnant nephrons: A potentially
adverse response to renal ablation. Am J Physiol 24l:F85, 1981
48. MoRRIsoN AB: Experimental renal insufficiency. Methods Achiev
Exp Pathol 1:455, 1966
49. SHIMAMURA T, MoRRISoN AB: A progressive glomerulosclerosis
occurring in partial five-sixths nephrectomy. Am J Pathol 79:95,
1975
50. FRIEND DG, H05KINs RG, KIRKIN MW: Relative erythrocythemia
(polycythemia) and polycystic kidney disease, with uremia. Report
of a case with comments on frequency of occurrence. NEnglJMed
264:17, 1961
51. GURNEY CW: Erythremia in renal disease. Trans AssocAmPhysi-
cians 73:103, 1960
52. ROSSE WF, WALDMANN TA, COHEN P: Renal cysts, erythropoietin
and polycythemia. Am J Med 34:76, 1963
